GSA CAPITAL PARTNERS LLP

Position in LXRX — Lexicon Pharmaceuticals, Inc.

CIK 1362033 LONDON, X0

Position in LXRX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$953,325

-$497,613 QoQ

Shares Held

397,219

-57.3% QoQ

Ownership

0.089%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#30

of 148 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. LXRX ranks #38 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	655,318	$2,726,122
2	IMVT	Immunovant, Inc.	65,267	$2,514,737
3	GOSS	Gossamer Bio, Inc.	14,986,947	$2,472,846
4	AXSM	Axsome Therapeutics, Inc.	9,419	$2,305,488
5	CABA	Cabaletta Bio, Inc.	668,563	$2,079,230
6	MLTX	MoonLake Immunotherapeutics	106,695	$2,077,351
7	ATYR	aTYR PHARMA INC	3,454,863	$2,062,553
8	CORT	Corcept Therapeutics Inc	23,257	$2,022,196

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$953,325	397,219	-57.3%	Shares	Sole	2026-08-06
2026-03-31	$1,450,938	930,089	-6.6%	Shares	Sole	2026-05-08
2025-12-31	$1,145,670	996,235	-17.2%	Shares	Sole	2026-02-06
2025-09-30	$1,623,923	1,202,906	-57.5%	Shares	Sole	2025-11-07
2025-06-30	$2,689,126	2,830,659	+250.5%	Shares	Sole	2025-07-22
2025-03-31	$371,446	807,492	+175.3%	Shares	Sole	2025-05-08
2024-03-31	$703,999	293,333	-62.4%	Shares	Sole	2024-05-03
2023-12-31	$1,193,517	780,077	+1017.7%	Shares	Sole	2024-02-16
2023-03-31	$169,592	69,791	-1.7%	Shares	Sole	2023-05-12
2022-09-30	$170,409	71,004	-80.9%	Shares	Sole	2022-11-14
2022-06-30	$691,172	371,598	+61.2%	Shares	Sole	2022-08-09
2022-03-31	$481,751	230,503	+630.3%	Shares	Sole	2022-05-11
2021-12-31	$124,354	31,562	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.